Distinct MHC Gene Expression Patterns During Progression of Melanoma

被引:30
作者
Degenhardt, Yan [1 ]
Huang, Jia [2 ]
Greshock, Joel [1 ]
Horiates, Galene [1 ]
Nathanson, Katherine [3 ,4 ]
Yang, Xiaolu [3 ,4 ]
Herlyn, Meenhard [5 ]
Weber, Barbara [6 ]
机构
[1] GlaxoSmithKline Inc, Canc Metab DPU, King Of Prussia, PA 19406 USA
[2] Univ Miami, Miami Inst Human Genom, Miami, FL USA
[3] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA
[4] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[5] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[6] Novartis Inst Biomed Res, Boston, MA USA
关键词
SQUAMOUS-CELL CARCINOMA; ANTIGEN-PROCESSING MACHINERY; CLASS-II GENES; T-CELLS; DOWN-REGULATION; BRAF MUTATIONS; TUMOR-CELLS; CANCER; LINES; ASSOCIATION;
D O I
10.1002/gcc.20728
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Abnormal expression of major histocompatibility complex l molecules in melanoma has been reported previously. However, the MHC molecule expression patterns in different growth phases of melanoma and the underlying mechanisms are not well understood. Here, we demonstrate that in vertical growth phase (VGP) melanomas, MHC genes are subject to increased rates of DNA copy number gains, accompanied by increased expression, in comparison to normal melanocytes. In contrast, MHC expression in metastatic melanomas drastically decreased compared to VGP melanomas, despite still prevalent DNA copy number gains. Subsequent investigations found that the master transactivator of MHC genes, CIITA, was also significantly downregulated in metastatic melanomas when compared to VGP melanomas. This could be one of the mechanisms accounting for the discrepancy between DNA copy number and expression level in metastatic melanomas, a potentially separate mechanism of gene regulation. These results infer a dynamic role of MHC function in melanoma progression. We propose potential mechanisms for the overexpression of MHC molecules in earlier stages of melanoma as well as for its downregulation in metastatic melanomas. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 47 条
[1]
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach? [J].
Altomonte, M ;
Fonsatti, E ;
Visintin, A ;
Maio, M .
ONCOGENE, 2003, 22 (42) :6564-6569
[2]
Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients [J].
Anichini, Andrea ;
Mortarini, Roberta ;
Nonaka, Daisuke ;
Molla, Alessandra ;
Vegetti, Claudia ;
Montaldi, Elisabetta ;
Wang, Xinhui ;
Ferrone, Soldano .
CANCER RESEARCH, 2006, 66 (12) :6405-6411
[3]
HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells [J].
Aoudjit, F ;
Guo, WY ;
Gagnon-Houde, JV ;
Castaigne, JG ;
Alcaide-Loridan, C ;
Charron, D ;
Al-Daccak, R .
EXPERIMENTAL CELL RESEARCH, 2004, 299 (01) :79-90
[4]
Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization [J].
Balázs, M ;
Adám, Z ;
Treszl, A ;
Bégány, A ;
Hunyadi, J ;
Adány, R .
CYTOMETRY, 2001, 46 (04) :222-232
[5]
Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma [J].
Byers, HR ;
Bhawan, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (04) :717-+
[6]
Immune selective pressure and HLA class I antigen defects in malignant lesions [J].
Chang, Chien-Chung ;
Ferrone, Soldano .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (02) :227-236
[7]
Distinct sets of genetic alterations in melanoma [J].
Curtin, JA ;
Fridlyand, J ;
Kageshita, T ;
Patel, HN ;
Busam, KJ ;
Kutzner, H ;
Cho, KH ;
Aiba, S ;
Bröcker, EB ;
LeBoit, PE ;
Pinkel, D ;
Bastian, BC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2135-2147
[8]
Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter [J].
Deffrennes, V ;
Vedrenne, J ;
Stolzenberg, MC ;
Piskurich, J ;
Barbieri, G ;
Ting, JP ;
Charron, D ;
Alcaïde-Loridan, C .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :98-106
[9]
Drozina G, 2005, CURR TOP MICROBIOL, V290, P147
[10]
LOSS OF HLA CLASS-I ANTIGENS BY MELANOMA-CELLS - MOLECULAR MECHANISMS, FUNCTIONAL-SIGNIFICANCE AND CLINICAL RELEVANCE [J].
FERRONE, S ;
MARINCOLA, FM .
IMMUNOLOGY TODAY, 1995, 16 (10) :487-494